Visualizar Tese - Instituto de Biociências - Unesp
Visualizar Tese - Instituto de Biociências - Unesp Visualizar Tese - Instituto de Biociências - Unesp
Cirilo, PDRREFERÊNCIAS221Martinez-Mir A, Glaser B, Chuang GS et al. Germline Fumarate Hydratase Mutations in Families withMultiple Cutaneous and Uterine Leiomyomata. J Invest Dermatol, 741-744, 2003.McCarroll SA, Kuruvilla FG, Korn JM et al. Integrated detection and population-genetic analysis ofSNPs and copy number variation. Nat Genet, 40, 1166-1174, 2008.Meadows KL, Andrews DM, Xu Z et al. Genome-wide analysis of loss of heterozygosity and copynumber amplification in uterine leiomyomas using the 100K single nucleotidepolymorphism array. Exp Mol Pathol, Epub ahead of print, 2011.Melchor L, Saucedo-Cuevas LP, Muñoz-Repeto I et al. Comprehensive characterization of the DNAamplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidatetarget genes. Breast Cancer Res, 11, R86, 2009.Meloni AM, Surti U, Sandberg AA. Deletion of chromosome 13 in leiomyomas of the uterus. CancerGenet Cytogenet, 53, 199-203, 1991.Mertens HJ, Heineman MJ, Theunissen PH et al. Androgen, estrogen and progesterone receptorexpression in the human uterus during the menstrual cycle. Eur J Obstet Gynecol ReprodBiol, 98, 58-65, 2001.Mesquita FS, Dyer SN, Heinrich DA et al. Reactive oxygen species mediate mitogenic growth factorsignaling pathways in human leiomyoma smooth muscle cells. Biol Reprod, 82, 341-351,2010.Meza-Zepeda LA, Kresse SH, Barragan-Polania AH et al. Array comparative genomic hybridizationreveals distinct DNA copy number differences between gastrointestinal stromal tumors andleiomyosarcomas. Cancer Res, 66, 8984-8993, 2006.Micci F, Teixeira MR, Haugom L et al. Genomic aberrations in carcinomas of the uterine corpus.Genes Chrom Cancer, 40, 229-246, 2004.Middlebrook BS, Eldin K, Li X et al. Smad1-Smad5 ovarian conditional knockout mice develop adisease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology,150, 5208-5217, 2009.Mills RE, Walter K, Stewart C et al. Mapping copy number variation by population-scale genomesequencing. Nature, 470, 59-65, 2011.Minelli L, Romagnolo C, Giambanco L et al. Uterine leiomyoma metastasis as a first sign of breastcancer. J Am Assoc Gynecol Laparosc, 5, 213-215, 1998.Misao R, Nakanishi Y, Fujimoto J et al. Expression of sex hormone-binding globulin mRNA in uterineleiomyoma, myometrium and endometrium of human subjects. Gynecol Endocrinol, 9, 317-323, 1995.Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2011). Mitelman F,Johansson B and Mertens F (Eds.), http://cgap.nci.nih.gov/Chromosomes/Mitelman.Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancercausation Nature Rev Cancer, 7, 233-245, 2007.
Cirilo, PDRREFERÊNCIAS222Mitra R, Lee J, Jo J et al. Prediction of Postoperative Recurrence-Free Survival in Non-Small CellLung Cancer by Using an Internationally Validated Gene Expression Model. Clin Cancer Res,17, 2934-2946, 2011.Mittal KR, Chen F, Wei JJ et al. Molecular and immunohistochemical evidence for the origin ofuterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas.Mod Pathol, 22, 1303–1311, 2009.Mittal KR and Joutovsky A. Areas with benign morphologic and immunohistochemical features areassociated with some uterine leiomyosarcomas. Gynecol Oncol, 104, 362–365, 2007.Mittal KR, Popiolek D, Demopoulos RI. Uterine myxoid leiomyosarcoma within a leiomyoma. HumPathol, 31, 398–400, 2000.Mizuochi T, Kimura A, Ueki I et al. Molecular genetic and bile acid profiles in two Japanese patientswith 3beta-hydroxy-DELTA5-C27-steroid dehydrogenase/isomerase deficiency. Pediatr Res,68, 258-263, 2010.Mo R, Rao SM, Zhu YJ. Identification of the MLL2 complex as a coactivator for estrogen receptoralpha. J Biol Chem, 281, 15714-15720, 2006.Mok SC, Bonome T, Vathipadiekal V et al. A gene signature predictive for outcome in advancedovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell,16, 521-532, 2009.Moore AB, Yu L, Swartz CD et al. Human uterine leiomyoma-derived fibroblasts stimulate uterineleiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF betareceptor signaling in coculture. Cell Commun Signal, 10, 8-10, 2010.Moore SD, Herrick SR, Ince TA et al. Uterine leiomyomata with t(10;17) disrupt the histoneacetyltransferase MORF. Cancer Res, 64, 5570–5577, 2004.Moorehead ME and Conard CJ. Uterine leiomyomas: a treatable condition. Ann N Y Acad Sci, 948,21-29, 2001.Müller M, Beck IM, Gadesmann J et al. MMP19 is upregulated during melanoma progression andincreases invasion of melanoma cells. Mod Pathol, 23, 511-521, 2010.Murnane JP. Telomere loss as a mechanism for chromosome instability in human cancer. CancerRes, 70, 4255-4259, 2010.Mylonas I, Brüning A, Shabani N et al. Evidence of inhibin/activin subunit betaC and betaE synthesisin normal human endometrial tissue. Reprod Biol Endocrinol, 19, 143, 2010.Nabokikh A, Ilhan A, Bilban M et al. Reduced TGF-beta1 expression and its target genes in humaninsulinomas. Exp Clin Endocrinol Diabetes, 115, 674-682, 2007.Napoli JL. Biochemical pathways of retinoid transport, metabolism, and signal transduction. ClinImmunol Immunopathol, 80, 52–62, 1996.
- Page 193 and 194: Cirilo, PDRDISCUSSÃO170sobre LHFPL
- Page 195 and 196: Cirilo, PDRDISCUSSÃO172outras cate
- Page 197 and 198: Cirilo, PDRDISCUSSÃO174Entre as ou
- Page 199 and 200: Cirilo, PDRDISCUSSÃO176regiões de
- Page 201 and 202: Cirilo, PDRDISCUSSÃO178da RNA Pol
- Page 203 and 204: Cirilo, PDRDISCUSSÃO180proliferati
- Page 205 and 206: Cirilo, PDRDISCUSSÃO182Entre os 20
- Page 207 and 208: Cirilo, PDRDISCUSSÃO184propôs um
- Page 209 and 210: Cirilo, PDRDISCUSSÃO186analisados
- Page 211 and 212: Cirilo, PDRDISCUSSÃO188observados
- Page 213 and 214: Cirilo, PDRDISCUSSÃO190moduladores
- Page 215 and 216: Cirilo, PDRDISCUSSÃO192genômica/d
- Page 217 and 218: Cirilo, PDRDISCUSSÃO194identificar
- Page 219 and 220: Cirilo, PDRDISCUSSÃO196e também d
- Page 221 and 222: Cirilo, PDRDISCUSSÃO198O gene COL3
- Page 223 and 224: Cirilo, PDRDISCUSSÃO200resistênci
- Page 225 and 226: Cirilo, PDRDISCUSSÃO202bioquímica
- Page 227 and 228: Cirilo, PDRDISCUSSÃO204carcinoma c
- Page 229 and 230: Cirilo, PDRCONCLUSÕES DISCUSSÃO20
- Page 231 and 232: Cirilo, PDRREFERÊNCIAS2087. Refer
- Page 233 and 234: Cirilo, PDRREFERÊNCIAS210Brazelle
- Page 235 and 236: Cirilo, PDRREFERÊNCIAS212Churikov
- Page 237 and 238: Cirilo, PDRREFERÊNCIAS214Gannon BR
- Page 239 and 240: Cirilo, PDRREFERÊNCIAS216Holthause
- Page 241 and 242: Cirilo, PDRREFERÊNCIAS218Kazmiercz
- Page 243: Cirilo, PDRREFERÊNCIAS220Lloret M,
- Page 247 and 248: Cirilo, PDRREFERÊNCIAS224Ozisik YY
- Page 249 and 250: Cirilo, PDRREFERÊNCIAS226Redon R,
- Page 251 and 252: Cirilo, PDRREFERÊNCIAS228Solyom S,
- Page 253 and 254: Cirilo, PDRREFERÊNCIAS230Ueki K, R
- Page 255 and 256: Cirilo, PDRREFERÊNCIAS232and poly(
- Page 257 and 258: Skubitz KM e Skubitz APJ Lab Clin M
- Page 259 and 260: Dimitrova IK et al. Fertil Steril,9
- Page 261 and 262: 317T_B317T_C13 614T 44 LU prolifera
- Page 263 and 264: 46 867T 46 LUM outros B 14 33,5 17
- Page 265 and 266: 1015T 6q13-q14.1 75,806,978-76,314,
- Page 267 and 268: MRPS31, SLC25A15, SUGT1L1 320d-1630
- Page 269 and 270: 8q22.3-q23.1 105,831,966 107,742,33
- Page 271 and 272: Anexo 5. Genes identificados na an
- Page 273 and 274: + + CCDC8 0 51 37 14+ - CALM3 51 0
- Page 275 and 276: ABSTRACTBackground: Uterine leiomyo
- Page 277 and 278: Thus, these findings prompt us to i
- Page 279 and 280: Technologies, Santa Clara, CA). Sta
- Page 281 and 282: mapped at 1p36.13, 1q41, 2q32.1, 2q
- Page 283 and 284: genetic disorder showed the higher
- Page 285 and 286: The modulators were mainly associat
- Page 287 and 288: egulation of cell cycle. Chegini an
- Page 289 and 290: REFERENCES[1] Baird DD, Dunson DB (
- Page 291 and 292: [37] Luo X, Ding L, Xu J et al. (20
- Page 293 and 294: AArray CGHExpression arrayBtumoral
Cirilo, PDRREFERÊNCIAS221Martinez-Mir A, Glaser B, Chuang GS et al. Germline Fumarate Hydratase Mutations in Families withMultiple Cutaneous and Uterine Leiomyomata. J Invest Dermatol, 741-744, 2003.McCarroll SA, Kuruvilla FG, Korn JM et al. Integrated <strong>de</strong>tection and population-genetic analysis ofSNPs and copy number variation. Nat Genet, 40, 1166-1174, 2008.Meadows KL, Andrews DM, Xu Z et al. Genome-wi<strong>de</strong> analysis of loss of heterozygosity and copynumber amplification in uterine leiomyomas using the 100K single nucleoti<strong>de</strong>polymorphism array. Exp Mol Pathol, Epub ahead of print, 2011.Melchor L, Saucedo-Cuevas LP, Muñoz-Repeto I et al. Comprehensive characterization of the DNAamplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidatetarget genes. Breast Cancer Res, 11, R86, 2009.Meloni AM, Surti U, Sandberg AA. Deletion of chromosome 13 in leiomyomas of the uterus. CancerGenet Cytogenet, 53, 199-203, 1991.Mertens HJ, Heineman MJ, Theunissen PH et al. Androgen, estrogen and progesterone receptorexpression in the human uterus during the menstrual cycle. Eur J Obstet Gynecol ReprodBiol, 98, 58-65, 2001.Mesquita FS, Dyer SN, Heinrich DA et al. Reactive oxygen species mediate mitogenic growth factorsignaling pathways in human leiomyoma smooth muscle cells. Biol Reprod, 82, 341-351,2010.Meza-Zepeda LA, Kresse SH, Barragan-Polania AH et al. Array comparative genomic hybridizationreveals distinct DNA copy number differences between gastrointestinal stromal tumors andleiomyosarcomas. Cancer Res, 66, 8984-8993, 2006.Micci F, Teixeira MR, Haugom L et al. Genomic aberrations in carcinomas of the uterine corpus.Genes Chrom Cancer, 40, 229-246, 2004.Middlebrook BS, Eldin K, Li X et al. Smad1-Smad5 ovarian conditional knockout mice <strong>de</strong>velop adisease profile similar to the juvenile form of human granulosa cell tumors. Endocrinology,150, 5208-5217, 2009.Mills RE, Walter K, Stewart C et al. Mapping copy number variation by population-scale genomesequencing. Nature, 470, 59-65, 2011.Minelli L, Romagnolo C, Giambanco L et al. Uterine leiomyoma metastasis as a first sign of breastcancer. J Am Assoc Gynecol Laparosc, 5, 213-215, 1998.Misao R, Nakanishi Y, Fujimoto J et al. Expression of sex hormone-binding globulin mRNA in uterineleiomyoma, myometrium and endometrium of human subjects. Gynecol Endocrinol, 9, 317-323, 1995.Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2011). Mitelman F,Johansson B and Mertens F (Eds.), http://cgap.nci.nih.gov/Chromosomes/Mitelman.Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancercausation Nature Rev Cancer, 7, 233-245, 2007.